Internal Medicine, Pulmonary Disease · Las Vegas, NV
NPI
1548296403
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2000 Wellness Way
Las Vegas, NV, 89106
Phone (702) 384-5101
Groups this clinician bills Medicare through
Medicare paid, 2024
$148K
3,019 services
Medicare patients, 2024
675
Average age 72
Drug cost, 2024
$1.5M
4,228 prescriptions
Company payments, 2025
$128
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul A Stewart was code 99233 (hospital e&m - subsequent), 378 times for 150 patients. In total Paul A Stewart billed 3,019 services in 26 codes, and Medicare paid $148K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 378 | 150 | $89.10 | $34K |
| 99457 E&M - Miscellaneous | Office | 336 | 61 | $37.28 | $13K |
| 99458 E&M - Miscellaneous | Office | 335 | 55 | $30.09 | $10K |
| 94010 Pulmonary Function Testing | Office | 243 | 233 | $19.70 | $4,786 |
| 99454 E&M - Miscellaneous | Office | 232 | 44 | $36.43 | $8,451 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 208 | 45 | $36.38 | $7,568 |
| 99213 Office E&M - Established | Office | 189 | 137 | $62.89 | $12K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 152 | 46 | $46.95 | $7,137 |
| 99232 Hospital E&M - Subsequent | Facility | 129 | 70 | $59.12 | $7,626 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 124 | 93 | $12.12 | $1,503 |
| 99214 Office E&M - Established | Office | 97 | 75 | $92.24 | $8,947 |
| 99223 Hospital E&M - Initial | Facility | 91 | 89 | $130.79 | $12K |
| 99212 Office E&M - Established | Office | 77 | 63 | $40.17 | $3,093 |
| 99204 Office E&M - New | Office | 63 | 63 | $113.97 | $7,180 |
| 99203 Office E&M - New | Office | 51 | 51 | $77.49 | $3,952 |
By year: 2022 $113K for 1,831 services; 2023 $117K for 1,773 services; 2024 $148K for 3,019 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul A Stewart prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 851 prescriptions and refills. In total Paul A Stewart wrote 4,228 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 851 | 1,172 | 200 | $738K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 598 | 657 | 199 | $18K |
| Prednisone Generic | 450 | 492 | 276 | $1,640 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 217 | 323 | 70 | $203K |
| Montelukast Sodium Generic | 198 | 426 | 72 | $1,535 |
| Breo Ellipta Fluticasone/Vilanterol | 188 | 262 | 36 | $105K |
| Levofloxacin Generic | 123 | 123 | 104 | $377 |
| Ventolin Hfa Albuterol Sulfate | 123 | 140 | 34 | $9,569 |
| Symbicort Budesonide/Formoterol Fumarate | 89 | 117 | 23 | $27K |
| Furosemide Generic | 79 | 124 | 45 | $345 |
| Ciprofloxacin Hcl Generic | 78 | 85 | 46 | $1,512 |
| Clarithromycin Generic | 68 | 72 | 28 | $4,497 |
| Fluconazole Generic | 65 | 67 | 45 | $1,482 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 59 | 69 | 24 | $31K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 57 | 93 | 17 | $9,160 |
Brand drugs: 2,280 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul A Stewart $128 ($128 in general payments such as food, travel and fees) from 2 companies. The largest payer was Sanofi-Aventis U.S. LLC with $92.99.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.